Literature DB >> 8605710

Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.

O Panzetta1, L Cominacini, U Garbin, A Fratta Pasini, L Gammaro, F Bianco, A Davoli, M Campagnola, A De Santis, A M Pastorino.   

Abstract

Oxidized low-density lipoproteins (LDL) play an important role in the pathogenesis of atherosclerosis. An increased sensitivity of red blood cell membranes to lipid peroxidation has been previously demonstrated in patients with chronic renal failure, suggesting that the antioxidant defence of lipoproteins might be impaired. Fish oil supplementation has been proposed in dialysis patients, but it is still unclear if the positive effects of fish oil depend only on its polyunsaturated fatty acid content or on other factors, such as the usually added antioxidants. Moreover, the increased concentration of highly peroxidable n-3 polyunsaturated fatty acids induced by fish oil in LDL particles could favour LDL oxidation and possibly the development of atherosclerosis. The present study was designed to evaluate the susceptibility of LDL to in vitro oxidation (lag phase) and the rate of lipid peroxidation (propagation phase) by fluorescence development during copper exposure in 14 hemodialysis patients. A further aim was to compare the effects on lipid metabolism and LDL oxidation of fish oil supplementation (20 ml containing vitamin E 20 IU as antioxidant) for 30 days and of vitamin E administration (50 IU) for another 30 days. The length of the lag phase and vitamin E concentration were significantly reduced (p < 0.01) in hemodialysis patients and increased significantly (p < 0.01) after administration of both fish oil and vitamin E. Fish oil supplementation also reduced plasma lipids significantly (p < 0.01) and increased the propagation phase (p < 0.01). Our results demonstrate that the susceptibility of LDL to oxidation is enhanced in hemodialysis patients, suggesting a possible relationship between excessive LDL peroxidation and accelerated atherosclerosis. The increased susceptibility of LDL to in vitro oxidation can be explained, at least partially, by a reduced LDL vitamin E concentration. Since fish oil increased the lag phase to the same extent as vitamin E supplementation, the positive effect of fish oil could be partly explained by its antioxidant content.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8605710

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  Antioxidants, cholesterol, and ischaemic heart disease: CHAOS or confusion?

Authors:  A F Winder
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

Review 2.  Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease.

Authors:  Francesco Galli; Mario Bonomini; Desirée Bartolini; Linda Zatini; Gianpaolo Reboldi; Giada Marcantonini; Giorgio Gentile; Vittorio Sirolli; Natalia Di Pietro
Journal:  Antioxidants (Basel)       Date:  2022-05-18

3.  Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.

Authors:  Katharina M Espe; Jens Raila; Andrea Henze; Katja Blouin; Andreas Schneider; Daniel Schmiedeke; Vera Krane; Stefan Pilz; Florian J Schweigert; Berthold Hocher; Christoph Wanner; Christiane Drechsler
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 8.237

4.  Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

Authors:  Jonathan Himmelfarb; T Alp Ikizler; Charles Ellis; Pingsheng Wu; Ayumi Shintani; Sanjay Dalal; Mark Kaplan; Michel Chonchol; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 10.121

5.  Changes in Oxidative Stress and Inflammatory Biomarkers in Fragile Adults over Fifty Years of Age and in Elderly People Exclusively Fed Enteral Nutrition.

Authors:  Maria D Mesa; Josune Olza; Carolina Gonzalez-Anton; Concepcion M Aguilera; Rosario Moreno-Torres; Africa Jimenez; Antonio Perez de la Cruz; Azahara I Ruperez; Angel Gil
Journal:  Oxid Med Cell Longev       Date:  2015-12-01       Impact factor: 6.543

Review 6.  Antioxidants for chronic kidney disease.

Authors:  Min Jun; Vinod Venkataraman; Mona Razavian; Bruce Cooper; Sophia Zoungas; Toshiharu Ninomiya; Angela C Webster; Vlado Perkovic
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.